StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30125% above fair value
$7.77−0.44 (-5.36%)

Close on Nov 16, 2026Market cap $417.16MP/E –Yield –

Alpha Teknova operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Alpha Teknova's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.27M. For fiscal 2025 it was -$8.65M. The highest annual figure on record is $2.51M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.65M–
FY2024Dec 31, 2024-$12.39M–
FY2023Dec 31, 2023-$18.81M–
FY2022Dec 31, 2022-$27.40M–
FY2021Dec 31, 2021-$9.07M-462.0%
FY2020Dec 31, 2020$2.51M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$471.00K–
Q1 FY2026Mar 31, 2026-$3.36M–
Q4 FY2025Dec 31, 2025-$462.00K–
Q3 FY2025Sep 30, 2025-$1.98M–
Q2 FY2025Jun 30, 2025-$2.10M–
Q1 FY2025Mar 31, 2025-$4.10M–
Q4 FY2024Dec 31, 2024-$936.00K–
Q3 FY2024Sep 30, 2024-$2.06M–
Q2 FY2024Jun 30, 2024-$2.84M–
Q1 FY2024Mar 31, 2024-$6.56M–
Q4 FY2023Dec 31, 2023-$2.89M–
Q3 FY2023Sep 30, 2023-$4.38M–
Q2 FY2023Jun 30, 2023-$3.86M–
Q1 FY2023Mar 31, 2023-$7.68M–
Q4 FY2022Dec 31, 2022-$8.03M–
Q3 FY2022Sep 30, 2022-$8.33M–
Q2 FY2022Jun 30, 2022-$5.84M–
Q1 FY2022Mar 31, 2022-$5.20M-316.6%
Q4 FY2021Dec 31, 2021-$3.08M-226.6%
Q3 FY2021Sep 30, 2021-$4.84M-373.7%
Q2 FY2021Jun 30, 2021-$3.55M–
Q1 FY2021Mar 31, 2021$2.40M–
Q4 FY2020Dec 31, 2020$2.43M–
Q3 FY2020Sep 30, 2020$1.77M–

More Alpha Teknova figures

See a number that looks wrong?